TrialJAMA oncology2019

Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial.

Gerald Falchook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.